期刊文献+

首发精神分裂症患者血浆白细胞介素6、免疫球蛋白G变化研究 被引量:1

Study on the alterations of plasma IL-6 and IgG in first episode schizophrenia
下载PDF
导出
摘要 目的 :研究首发偏执型精神分裂症患者血浆中白细胞介素 6 (IL 6 )、免疫球蛋白G(IgG)的变化。 方法 :对首发偏执型精神分裂症患者 30例 ,单独应用氯氮平治疗 ;2 0例健康志愿者为对照组。采用酶联免疫吸附法测定血浆中IL 6的浓度 ,应用速率散射比浊法检测IgG的血浆浓度 ,并进行组间比较。 结果 :精神分裂症组在治疗前血浆IL 6、IgG的水平显著增高 ,治疗 6周症状缓解后仍显著增高 ;症状基本缓解后与治疗前比较差异无显著性。 结论 :精神分裂症患者存在免疫功能紊乱。 Objective:To evaluate the alterations of plasma interleukin 6 (IL-6) and immunoglobulin G(IgG) in first episode paranoid schizophrenia. Method:30 inpatients with first episode paranoid schizophrenia were collected as case group and treated with clozapine.We obtained plasma when schizophrenic patients were both on admission and in a state of initial remission 6 weeks after admission.20 healthy volunteers were enrolled as control group.The contents of IL-6 were measured with enzyme-linked immunosorbent assay (ELISA).The contents of IgG were measured with rate nephelometry.The parameters were performed by statistics analysis. Results:On admission,the levels of IL-6 and IgG in plasma were significantly higher in schizophrenic patients in comparison to control group.Six weeks after admission,the levels of IL-6 and IgG in plasma were significantly higher in comparison to control group.When initial remission compared with acute disease,no pronounced difference was observed for the levels of IL-6 and IgG in plasma. Conclusion:Schizophrenic patients had immune dysfunction.
出处 《临床精神医学杂志》 2003年第6期340-341,共2页 Journal of Clinical Psychiatry
关键词 精神分裂症 白细胞介素6 免疫球蛋白G 氯氮平 Schizophrenia Interleukin 6 Immunoglobulin G Clozapine
  • 相关文献

参考文献8

  • 1[1]Maes M, Bocchi-Chiavetto L, Bignottis, et al. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur-Neuropsychopharmacol,2000, 10:119-124.
  • 2[2]Kim YK, Kim MJ, Lee MS, et al. Relationship between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics.Schizophr- Res, 2000,44:165-175.
  • 3[3]Maes M, Bocchio-Chiavetto L, Bignotti S, et al. Effects of atypicalantipsychotics on the inflamm-atory reponse system in schizophrenic patients ressistant to treatment with typical neuroleptics. Eur-Neuropsychopharmacol, 2000,10:119-124.
  • 4[4]Hinze-Selch D, Becker EW, Stein GM, et al. Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine treated schizophrenicpatients. Neuropsychopharmacology, 1998,19: 114-122.
  • 5[5]Sasaki T, Nanko S, Fukuda R. Changes of immunological functions after acute exacerbation in schizophrenia. Biol Psychiatry, 1994,35:173-178.
  • 6[6]Levy-Soussan P, Berneman A, Poirier MF, et al. Differences in the natural autoantibody patterns of patients with schizophrenia and normal individuals. J Psychiatry Neurosci, 1996,21: 89-95.
  • 7[7]Cazzulo CL, Saresella M, Roda K, et al. Increased levels of CD8+ and CD4+ 45+RA lymphocytes in schizophrenic patients. Schizophr-Res, 1998,31:49-55.
  • 8[8]Rothermundt M, Arolt V, Weitzsch C, et al. Immunological dysfunction in schizophrenia: a systematic approach. Neuropsychobiology, 1998,37: 186-193.

同被引文献12

  • 1纪菊英,徐乐平,汪莉,施辉,端义扬,邵亚琴,仲爱芳.糖化血红蛋白预测抗精神病药对糖代谢的影响[J].临床精神医学杂志,2005,15(6):327-329. 被引量:1
  • 2徐乐平,纪菊英,端义扬,施辉,张斌,邵亚琴,孙剑.糖化血红蛋白异常在抗精神病药诱发糖代谢疾病中的意义[J].中华精神科杂志,2006,39(1):1-4. 被引量:5
  • 3林建荣,张良,彭红军,冯容妹,温预关,郑东,侯静,黄煜坤,杨婵娟,梁绍材,徐贵云,邓德清,徐建雄,刘国雄,王春江,李英,张冬梅.氯氮平、氟哌啶醇和氯丙嗪对慢性精神分裂症患者糖、脂代谢及体质量的影响[J].中华精神科杂志,2006,39(2):73-77. 被引量:34
  • 4Kirch DJ.Infection and autoimmunity as etilolgic factors in schizophrenia: A review and reappraisal[J]. Schizophr Bull, 1993, 19:355 - 370.
  • 5Ganguli R, Yang Z, Shurin G, et al. Serum interleukin - 6 concentration in schizophrenia elevaties associated with duration of illness [J]. Psychiatry Res, 1994,51 ( 1 ) : 1 - 9.
  • 6Naudin J, Mege JL, Azorin JM, et al. Elevated circulation levels of IL-6 in schizophrenia[J]. Schizophrenia Res, 1996, 20(3): 269 - 271.
  • 7Maes M, Boc chio - Chiavetto L, Bignotti S, et al. Effects of atypicalantipsychotics on the inflamm - atory reponse system in schizophrenic patients resistant to treatment with typical neuroleptics[J]. Eur - Neuropsychopharmacol, 2000,10:119 - 124.
  • 8Hinze - Selch D, Becker EW, Stein GM, et al. Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine treated schizophrenicpatients [J]. Neuropsychopharmacology, 1998,19 : 114 - 122.
  • 9De Hert M, Van Winkel R, Van Eyck D, et al. Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study[J] .Clin Pract Epidemol Ment Health,2006,2: 14.
  • 10Zalcman S, Greefn - Joknson JM, Murray L, et al. Cytokine - specific central mononamine alterations induced by interleukin - 1, - 2 and - 6 [ J ]. Brain Res, 1994,643 ( 1 ) : 40.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部